Identification of hepatotoxicity related genes induced by toxaphene in HepG2 cells

Molecular and Cellular Toxicology

Volumn 7, Issue 1, 2011, Pages 53-60

  Choi, Han Saem ^a   Kim, Youn Jung ^b   Song, Mee ^a   Song, Mi Kyung ^a   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Gene ontology (GO); Microarray; Persistent Organic Pollutants (POPs); Toxaphene

Indexed keywords

EID: 79960103323     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-011-0008-y     Document Type: Article

References (27)

1. Namìeśnik, J. et al. Passive sampling and/or extraction techniques in environmental analysis: a review. Anal Bioanal Chem 381:279-301 (2005). (Pubitemid 40249150)
2. Ribas-Fitó, N., Sala, M., Kogevinas, M. & Sunyer, J. Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review. J Epidemiol Community Health 55:537-546 (2001). (Pubitemid 32662054)
3. Snedeker, S. M. Pesticides and breast cancer risk: a review of DDT, DDE, and Dieldrin. Environ Health Perspect 109(suppl 1):35-47 (2001). (Pubitemid 32303229)
4. Parlar, H. Commentary on toxaphene as it degrades in the environment. Fresen Environ Bull 15:1330-1335 (2006). (Pubitemid 44901503)
5. Purdue, M. P., Hoppin, J. A., Blair, A., Dosemeci, M. & Alavanja, M. C. Occupational exposure to organochlorine insecticides and cancer incidence in the agricultural health study. Int J Cancer 120:642-649 (2007). (Pubitemid 44969036)
6. Karl, H., Khandker, S. & Alder, L. Variation of toxaphene indicator compounds in fish from single fishing grounds: conclusions for sampling. Chemosphere 39:2497-2506 (1999). (Pubitemid 29485980)
7. Angerhofer, D. et al. The role of biotic and abiotic degradation processes during the formation of typical toxaphene peak patterns in aquatic biota. Chemosphere 39:563-568 (1999). (Pubitemid 29295139)
8. Gill, U. S., Schwartz, H. M., Wheatley, B. & Parlar, H. Congener specific analysis of toxaphene in serum using ECNI-S. Chemosphere 33:1021-1025 (1996). (Pubitemid 26280459)
9. Parlar, H., Leupold, G., Reil, G., Angerhofer, D. & Coelhan, M. Structure -X environmental degradation relationship model for toxaphene congeners. Fresen Environ Bull 10:4-7 (2001).
10. Ryu, J. C., Kim, M. K., Choi, M. H. & Chun, T. H. Promising next generation technology in toxicologytoxicogenomics. Mol Cell Toxicol 1:1-6 (2005).
11. Sarma, S. N., Kim, Y. J., Jeon, H. K. & Ryu, J. C. Identification of immune responsive genes on benzene, toluene and o-xylene in jurkat cells using 35 k human oligomicroarray. Mol Cell Toxicol 2:229-235 (2006).
12. Aardema, M. J. & MacGregor, J. T. Toxicology andgenetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat Res 499:13-25 (2002). (Pubitemid 34137071)
13. Nishimoto, S. & Nishida, E. MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782-786 (2006). (Pubitemid 44275395)
14. Soultati, A. & Dourakis, S. P. Coagulation disorders in liver diseases. Haema 9:31-44 (2006).
15. Garred, P. Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans 36:1461-1466 (2007).
16. Takahashi, K. Lessons learned from murine models of mannose-binding lectin deficiency. Biochem Soc Trans 36:1487-1490 (2008).
17. Benedicto, I. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 48:1044-1053 (2008).
18. Smith, M. W. et al. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 63:859-864 (2003). (Pubitemid 36231988)
19. Iizuka, N. et al. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray. Int J Oncol 24:565-574 (2004).
20. Mao, H. J., Li, H. N., Zhou, X. M., Zhao, J. L. & Wan, D. F. Monitoring microarray-based gene expression profile changes in hepatocellular carcinoma. World J Gastroenterol 11:2811-2816 (2005).
21. Yang, L. Y., Wang, W., Peng, J. X., Yang, J. Q. & Huang, G. W. Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma. World J Gastroenterol 10:3569-3573 (2004). (Pubitemid 39619270)
22. Kurokawa, Y. et al. Molecular features of non-B, non-C hepatocellular carcinoma: a PCRarray gene expression profiling study. J Hepatol 39:1004-1012 (2003). (Pubitemid 37523773)
23. Mosnier, L. O., Buijtenhuijs, P., Marx, P. F., Meijers, J. C. & Bouma, B. N. Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101:4844-4846 (2003). (Pubitemid 36857744)
24. Hori, Y. et al. Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients. J Clin Endocrinol Metab 87:660-665 (2002). (Pubitemid 34158234)
25. Hori, Y. et al. Insulin enhanced thrombin-activable fibrinolysis inhibitor expression through PI3 kinase/ Akt pathway. Int J Mol Med 15:265-268 (2005).
26. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63 (1983). (Pubitemid 14203433)
27. Park, H. W. et al. Gene expression patterns of environmental chemicals in human cell lines using HazChem human array. BioChip J 3:65-70 (2009).